Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 1,040 | 925 | 2,042 | 4,404 | 1,839 |
| Cost of Goods | N/A | N/A | 125 | 267 | 148 |
| Gross Profit | 1,040 | 925 | 1,917 | 4,137 | 1,691 |
| Operating Expenses | 19,586 | 4,056 | 5,846 | 8,720 | 9,715 |
| Operating Income | -18,546 | -3,131 | -3,804 | -4,316 | -7,876 |
| Interest Expense | 6 | 582 | 279 | 608 | 0 |
| Other Income | 4,026 | -23,065 | 8,532 | -5,608 | 5,361 |
| Pre-tax Income | -14,526 | -26,778 | 4,449 | -10,532 | -2,515 |
| Income Tax | N/A | N/A | N/A | N/A | 17 |
| Net Income Continuous | -14,526 | -26,778 | 4,449 | -10,532 | -2,532 |
| Net Income | $-14,526 | $-26,778 | $4,449 | $-10,532 | $-2,532 |
| EPS Basic Total Ops | -13.25 | -381.50 | 76.75 | -650.00 | -275.00 |
| EPS Basic Continuous Ops | -13.16 | -344.56 | 220.31 | -544.49 | -158.38 |
| EPS Diluted Total Ops | -13.25 | -381.50 | 76.00 | -650.00 | -275.00 |
| EPS Diluted Continuous Ops | -13.16 | -344.56 | 218.31 | -544.49 | -158.38 |
| EBITDA(a) | $-17,995 | $-3,120 | $-3,801 | $-3,897 | $-7,643 |